Post-Operative Rehabilitation of Knee Osteochondral Defect: A Case Series

February 7, 2019 updated by: California State University, Northridge

Examination and Post-operative Rehabilitation of University Athletes With Osteochondral Lesions of the Knee: A Case Series Report

A case-series review was performed on five collegiate athletes with osteochondral lesions of the knee at California State University, Northridge (CSUN). All subjects received surgical intervention to treat the defect. The surgeries performed were either an Osteoarticular Transfer System (OATS) procedure and/or a Microfracturing procedure. Subjects were treated post-operatively by the CSUN team physical therapist and/or athletic trainers at CSUN. This paper seeks to provide information about osteochondral defects of the knee, the surgical interventions, and a protocol for post-operative treatment and rehabilitation of such injuries.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

5

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Northridge, California, United States, 91330
        • California State University, Northridge

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The subjects were recruited from a population of student athletes at California State University, Northridge. These athletes were being treated by the Physical Therapy and/or Athletic Training Departments for Osteochondral Defect of the knee.

Description

Inclusion Criteria:

  • Student athlete at CSUN
  • Diagnosed with Osteochondral dissecans (OCD)
  • Underwent surgical procedure to treat OCD
  • Treated postoperatively by the team physical therapist and/or athletic trainers at CSUN.

Exclusion Criteria:

- No concurrent ligamentous injures to the knee during the time of subject participation in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of Function
Time Frame: Through study completion; an average of 6 months
Determined by subject's ability to return to play of his/her respective sport
Through study completion; an average of 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: Monthly until the completion of the study; an average of 6 months
Pain as measured by the Visual Analog Scale (VAS), 0 (No pain) - 10 (Severe Pain)
Monthly until the completion of the study; an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aimie Kachingwe, PT, DPT, EdD, OCS, FAAOMPT, CSUN Physical Therapy Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2011

Primary Completion (ACTUAL)

November 1, 2018

Study Completion (ACTUAL)

November 1, 2018

Study Registration Dates

First Submitted

February 9, 2018

First Submitted That Met QC Criteria

February 28, 2018

First Posted (ACTUAL)

March 2, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 11, 2019

Last Update Submitted That Met QC Criteria

February 7, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteochondritis Dissecans

Subscribe